LOL! Reality is that REGEN has done nothing to make it worth investing in. No clinical trial for hemax until 3rd Quarter and that's not guaranteed. Regen hasn't even contracted with a company yet to do the trial! With years of delay and knowing that FDA approval would be imminent you'd think they'd have it all lined up. But nope. Nothing. Zip. And good luck trying to get non dilutive financing in these trying economic times if you are a fledgling biotech. No one is buying this company. The one shot to validate the science in a clinical trial isn't happening. And people wonder why the stock is tanking? Geesh.
News 
Market Data 
Discover 
